-
-
-
-
-
-
-
Sensei Biotherapeutics (SNSE) Reiterated at Overweight by Cantor Fitzgerald
-
-
-
-
-
-
-
Leerink Reiterates Outperform Rating on Nuvalent (NUVL)
-
-
-
-
-
-
-
Goldman Sachs on Vera Therapeutics (VERA): 'We are encouraged by today's update'
-
-
-
-
-
-
-
Unicycive Therapeutics (UNCY) PT Raised to $18 at Benchmark
-
-
-
-
-
-
-
Vera Therapeutics Announces Alignment with U.S. FDA on Earlier ORIGIN Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults with IgA Nephropathy
-
-
-
-
-
-
-
PolyPid completes FDA submission for surgical infection prevention drug
-
-
-
-
-
-
-
FDA accepts Bristol Myers Squibb Camzyos application for adolescent treatment
-
15,437 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

